It is a trading private limited company based in East Delhi, Delhi, India, established in 2015.
2015 | East Delhi, Delhi, India | ActiveKalite Pharmaceuticals Private Limited, a active private limited company, was established on 11 May 2015 in East Delhi, Delhi, India. Engaging in other wholesale within the trade sector, it holds CIN: U51909DL2015PTC279920. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Bipin Kumar (Director), Alok Kumar Singh (Director), Arun Kumar Sinha (Director). Past directors included Swati Srivastava, Arun Kumar Sinha, Lata Sinha. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No. 4&5 F/F, Veer Savarkar Block, East Delhi, Delhi, 110092.
U51909DL2015PTC279920
279920
11 May 2015
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Kalite Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bipin Kumar | Director | 20 Mar 2021 | Current |
| Alok Kumar Singh | Director | 11 May 2021 | Current |
| Arun Kumar Sinha | Director | 20 Sep 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Dec 2018 | Past |
| Pramod Abcsdd | Director | 10 Mar 2018 | Past |
| Pramod Abcsdd | Director | 25 Sep 2023 | Past |
| Pramod Abcsdd | Director | 20 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kalite Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 11.52% increase in profit. The company's net worth observed a substantial decline by a decrease of 68.5%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Kalite Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kalite Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kalite Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kalite Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kalite Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Kalite Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Arun Kumar Sinha was appointed as a Director was appointed as a Director on 20 Sep 2023 & has been associated with this company since 2 years 2 months . was recorded as a recent event.
Alok Kumar Singh was appointed as a Director was appointed as a Director on 11 May 2021 & has been associated with this company since 4 years 6 months . was recorded as a recent event.
Bipin Kumar was appointed as a Director was appointed as a Director on 20 Mar 2021 & has been associated with this company since 4 years 8 months . was recorded as a recent event.
Kalite Pharmaceuticals Private Limited was registered on 11 May 2015 with Roc Delhi & aged 10 years 6 months as per MCA records. was recorded as a recent event.
The CIN of Kalite Pharmaceuticals Private Limited is U51909DL2015PTC279920.
Kalite Pharmaceuticals Private Limited is headquartered at H.No. 4&5 F/F, Veer Savarkar Block, East Delhi, Delhi, 110092.
Kalite Pharmaceuticals Private Limited was incorporated on 11 May 2015.
The current directors of Kalite Pharmaceuticals Private Limited are
The primary industry of Kalite Pharmaceuticals Private Limited is Trade.
Kalite Pharmaceuticals Private Limited is unlisted.
The authorized capital of Kalite Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Kalite Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX